XML 75 R56.htm IDEA: XBRL DOCUMENT v3.3.1.900
BUSINESS ACQUISITIONS (Narrative) (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Nov. 16, 2015
Aug. 03, 2015
Apr. 18, 2014
Apr. 16, 2014
Mar. 07, 2014
Jan. 02, 2013
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Business Acquisition [Line Items]                                  
Business acquisitions, net of cash acquired                             $ 67 $ 728 $ 213
Net revenues             $ 1,849 $ 1,880 $ 1,925 $ 1,839 $ 1,883 $ 1,904 $ 1,902 $ 1,746 7,493 7,435 7,146
Total consideration                                 $ 264
Estimated fair value of contingent consideration     $ 26                            
MemorialCare [Member]                                  
Business Acquisition [Line Items]                                  
Cash   $ 35                              
Superior Mobile Medics, Inc. [Member]                                  
Business Acquisition [Line Items]                                  
Cash $ 27                                
Solstas Lab Parnters Group [Member]                                  
Business Acquisition [Line Items]                                  
Cash         $ 572                        
Business acquisitions, net of cash acquired         563                        
Net revenues                               300  
Operating costs and expenses                               294  
Integration and transaction related costs                               17  
Total consideration         572                        
Transaction related costs due to sellers         0                        
Estimated fair value of contingent consideration         $ 0                        
Solstas Lab Parnters Group [Member] | Cost of Services [Member]                                  
Business Acquisition [Line Items]                                  
Integration and transaction related costs                               4  
Solstas Lab Parnters Group [Member] | Selling, General and Administrative Expenses [Member]                                  
Business Acquisition [Line Items]                                  
Integration and transaction related costs                               13  
Summit Health, Inc. [Member]                                  
Business Acquisition [Line Items]                                  
Cash     125                            
Business acquisitions, net of cash acquired     124                            
Total consideration     152                            
Working capital adjustments     10                            
Transaction related costs due to sellers     5                            
Estimated fair value of contingent consideration     22                            
Contingent consideration arrangements, range of outcomes, value, high     $ 25                            
Summit Health, Inc. [Member] | To be Paid in 2016 Based on Revenue Targets [Member]                                  
Business Acquisition [Line Items]                                  
Estimated fair value of contingent consideration             0       $ 13       0 $ 13  
Steward Health Care Systems, LLC [Member] [Member]                                  
Business Acquisition [Line Items]                                  
Cash       $ 30                          
Total consideration       34                          
Estimated fair value of contingent consideration       4                          
Contingent consideration arrangements, range of outcomes, value, high             $ 4               $ 4    
Steward Health Care Systems, LLC [Member] [Member] | Non-compete Agreements [Member]                                  
Business Acquisition [Line Items]                                  
Contingent consideration arrangements, range of outcomes, value, high       $ 5                          
UMass [Member]                                  
Business Acquisition [Line Items]                                  
Deferred liability           $ 50                      
Percentage of equity interest expected to be divested           18.90%